Clinical Scorecard: The Impact of Obesity on Outcomes Following STEMI: Positive Insights for Overweight and Moderately Obese Patients
At a Glance
Category
Detail
Condition
ST-elevation myocardial infarction (STEMI)
Key Mechanisms
Obesity influences cardiovascular risk profiles and disease progression; overweight and mild obesity associated with lower mortality post-STEMI compared to normal weight or severe obesity
Target Population
Patients with STEMI across BMI categories, especially overweight and mildly obese adults
Care Setting
Acute and post-acute cardiovascular care settings including hospital and follow-up outpatient management
Key Highlights
Severe obesity (BMI ≥40 kg/m²) linked to higher short- and long-term mortality after STEMI.
Overweight (BMI 25 to <30 kg/m²) and mild obesity (BMI 30 to <35 kg/m²) groups show lowest mortality post-STEMI.
Normal BMI patients have higher mortality than overweight/mildly obese patients, confirming a U-shaped BMI-mortality relationship.
Guideline-Based Recommendations
Diagnosis
Assess BMI in all STEMI patients to stratify risk and understand metabolic profiles.
Management
Recognize that overweight and mild obesity may confer survival advantages post-STEMI.
Tailor secondary prevention strategies considering the differentiated impact of BMI categories on outcomes.
Monitoring & Follow-up
Monitor cardiovascular risk factors and comorbidities especially in severely obese patients.
Follow-up for 5 years post-STEMI to assess mortality and cardiovascular events across BMI groups.
Risks
Severe obesity is associated with accelerated atherosclerosis, hypertension, diabetes, and increased mortality.
Normal weight patients may have higher mortality risk than overweight/mildly obese patients post-STEMI.
Patient & Prescribing Data
Over 11,000 consecutive STEMI patients from 2006 to 2022, including BMI categories from normal weight to severe obesity.
Overweight and mildly obese patients had better survival outcomes despite similar procedural and treatment characteristics compared to normal weight and severely obese patients.
Clinical Best Practices
Incorporate BMI assessment into STEMI patient evaluation to guide prognosis.
Avoid uniform weight loss recommendations post-STEMI; consider individualized approaches based on BMI and metabolic status.
Recognize the obesity paradox in cardiovascular disease management and adjust secondary prevention accordingly.
